<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02150265</url>
  </required_header>
  <id_info>
    <org_study_id>2011/1937</org_study_id>
    <secondary_id>8563/PFP1112-13</secondary_id>
    <nct_id>NCT02150265</nct_id>
  </id_info>
  <brief_title>Effectiveness of Six Sessions CBT for Adolescents With Emotional Problems in Community Clinics</brief_title>
  <acronym>SMART</acronym>
  <official_title>Effectiveness of Cognitive Behavioral Short-term Treatment for Adolescents With Emotional Symptom Problems in Community Clinics in Norway. A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Tromso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Royal Norwegian Ministry of Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regionsenter for barn og unges psykiske helse</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Tromso</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: There is need for more effectiveness studies concerning treatment of emotional
      symptom problems indicating anxiety and depression in adolescents. SMART is the only
      treatment manual for combined emotional disorders developed in Norwegian.

      Purpose: To find the best individualized treatment for adolescents with emotional
      difficulties by: Finding criteria for the selection of appropriate patients for treatment
      with cognitive-behavior therapy program SMART in an outpatient population (14-18 years).
      Finding predictors of completion of treatment program SMART. Examining the effects of
      treatment with the SMART program at 6 months follow-up.

      Design: A randomized controlled study in six outpatient clinics in the north of Norway. N=
      160 referred adolescents (14-18 years) with score above 6 on the Emotional Problems scale of
      the Strength and Difficulties Questionnaire (SDQ). Two thirds are treated according to the
      SMART-manual immediately, while the waiting list control group is treated with SMART after
      six weeks.

      Hypothesis: The SMART treatment is an effective treatment for emotional symptom problems.

      Publication: The results sought published internationally and nationally and will be
      communicated to clinicians.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2013</start_date>
  <completion_date type="Actual">March 1, 2018</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Status of primary emotional disorder based on theDevelopment and Well-Being Assessment (DAWBA) interview schedule with parents and youths</measure>
    <time_frame>At recruitment, before treatment start and at 6 months follow up</time_frame>
    <description>Diagnostic interview</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SDQ Strengths and Difficulties Questionnaire</measure>
    <time_frame>At recruitment, before treatment start and at 6 months follow up</time_frame>
    <description>Measure of general emotional and behavioral symptoms and strengths</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety symptom score on the Multi-Dimensional Anxiety Scale for Children (MASC)</measure>
    <time_frame>At recruitment, before treatment start and at 6 months follow up</time_frame>
    <description>Measure of anxiety symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression symptom status as measured by the self-rating instrument Beck Depression Inventory (BDI-II)</measure>
    <time_frame>At recruitment, before treatment start and at 6 months follow up</time_frame>
    <description>Measure of depressive symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life functioning as measured by the rating scale C-GAS rated by clinicians</measure>
    <time_frame>At recruitment, before treatment start and at 6 months follow up</time_frame>
    <description>Measure of functioning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General outcome measured by Clinical Outcomes in Routine Evaluations Outcome Measure (CORE-OM)</measure>
    <time_frame>At recruitment, before treatment start and at 6 months follow up. The short version (CORE 10) mid-therapy: 3 weeks after starting treatment</time_frame>
    <description>Measure of symptoms, risk, functioning and total burden of disorder</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">163</enrollment>
  <condition>Generalized Anxiety Disorder</condition>
  <condition>Social Phobia</condition>
  <condition>Agoraphobia</condition>
  <condition>Depression</condition>
  <condition>Panic Disorder</condition>
  <arm_group>
    <arm_group_label>Waiting list control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>6 week waiting list</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Individual cognitive behavioral therapy with SMART</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SMART manual cognitive behavioral therapy individual weekly sessions for 6 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMART manual cognitive behavioral therapy</intervention_name>
    <arm_group_label>Individual cognitive behavioral therapy with SMART</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age 14 to 18 years Referred to Community Mental Health Clinic for Children and Adolescents

          -  Score above 6 on Emotional symptoms scale on the SDQ Fluent Norwegian language

        Exclusion Criteria:

          -  Indicators for Pervasive Developmental Disorder (PDD) Acute suicidal symptoms
             Psycho-active drug treatment start coinciding with start of intervention Symptoms
             indicating psychotic disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingunn Skre, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UiT Arctic University of Norway</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Simon-Peter Neumer, Dr philos</last_name>
    <role>Study Chair</role>
    <affiliation>Regionsenter for barn og unges psykiske helse, Sør-Øst</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of North Norway</name>
      <address>
        <city>Tromsø</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 26, 2014</study_first_submitted>
  <study_first_submitted_qc>May 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2014</study_first_posted>
  <last_update_submitted>May 21, 2019</last_update_submitted>
  <last_update_submitted_qc>May 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Panic Disorder</mesh_term>
    <mesh_term>Phobia, Social</mesh_term>
    <mesh_term>Agoraphobia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

